Trial
NCT04544007
A Phase II Trial of Poly-ICLC for Low-Grade Gliomas
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
University of Alabama at Birmingham
Collaborators
Children's Healthcare of Atlanta; Children's Hospital Los Angeles
Condition
NF1
Intervention
Poly ICLC
Why stopped
The closure of the study is due to the lack of enrollment and the lack of evaluable patients.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-03-21